RTC
DXCM icon

Riverview Trust Company’s DexCom DXCM Stock Holding History

Riverview Trust Company’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-471
Closed -$36.6K – 670
2024
Q4 		$36.6K Buy
471
+8
+2% +$592 0.03% 272
2024
Q3 		$31K Buy
463
+232
+100% +$19.1K 0.03% 319
2024
Q2 		$26.2K Hold
231
– – 0.02% 349
2024
Q1 		$32K Buy
+231
New +$29K 0.02% 319
2023
Q4 		– Sell
-165
Closed -$15.4K – 245
2023
Q3 		$15.4K Hold
165
– – 0.01% 515
2023
Q2 		$21.2K Hold
165
– – 0.02% 340
2023
Q1 		$19.2K Hold
165
– – 0.02% 357
2022
Q4 		$19K Hold
165
– – 0.02% 346
2022
Q3 		$13K Buy
+165
New +$14K 0.01% 501
2022
Q2 		– Sell
-192
Closed -$25K – 746
2022
Q1 		$25K Buy
+192
New +$21K 0.02% 384

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Riverview Trust Company's DXCM Position: Q1 2025 in Review

Riverview Trust Company sold out of DexCom (DXCM) in Q1 2025, closing a stake of 471 shares — an estimated $36.6K sold.

Riverview Trust Company first reported a position in DXCM in Q1 2022 and held it in 10 quarters. The position peaked at $36.6K in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Riverview Trust Company reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 471 DexCom shares in Q1 2025, an estimated $36.6K.
  • Riverview Trust Company first reported a position in DexCom in Q1 2022 and held it in 10 quarters.
  • Riverview Trust Company's DexCom position peaked at $36.6K in Q4 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.